Mechanism of aucubin in regulating ribosome biogenesis and inhibiting injury of nucleus pulposus cells and extracellular matrix degradation.
10.19540/j.cnki.cjcmm.20240802.401
- Author:
Ling-Hui LI
1
;
Shang-Quan WANG
1
;
Kai SUN
1
;
Xun-Lu YIN
1
;
Li-Guo ZHU
1
;
Xu WEI
1
Author Information
1. Wangjing Hospital of China Academy of Chinese Medical Sciences Beijing 100102, China Beijing Key Laboratory of Orthopaedic Technology of Traditional Chinese Medicine Beijing 100102, China.
- Publication Type:Journal Article
- Keywords:
PI3K/mTOR;
aucubin;
cell apoptosis;
nucleus pulposus cells;
ribosome biogenesis
- MeSH:
Nucleus Pulposus/cytology*;
Extracellular Matrix/drug effects*;
Animals;
Iridoid Glucosides/pharmacology*;
Apoptosis/drug effects*;
Interleukin-1beta/metabolism*;
Phosphatidylinositol 3-Kinases/genetics*;
Rats;
Cell Proliferation/drug effects*;
TOR Serine-Threonine Kinases/genetics*;
Rats, Sprague-Dawley;
Humans;
Signal Transduction/drug effects*;
Caspase 3/genetics*;
Proto-Oncogene Proteins c-bcl-2/genetics*
- From:
China Journal of Chinese Materia Medica
2024;49(21):5713-5720
- CountryChina
- Language:Chinese
-
Abstract:
This study aimed to investigate the effect of aucubin(AU) on injury of nucleus pulposus cells and extracellular matrix(ECM) degradation and its mechanism. The nucleus pulposus cell injury model was established by interleukin-1β(IL-1β) and treated with AU or phosphatidylinositol 3-kinase(PI3K) inhibitor LY294002. CCK-8 experiment was conducted to test cell proliferation. EdU staining method was employed to detect cell injury. Flow cytometry was used to detect cell apoptosis. Western blot was used to detect protein levels of cleaved-caspase-3, B-cell lymphoma(Bcl-2), Bcl-2 associated X protein(Bax), type Ⅱ collagen(collagen Ⅱ), aggregation proteoglycans(aggrecan), PI3K, and mammalian target of rapamycin(mTOR). qPCR was used to detect the rRNA level of 5S, 18S, and 28S. Ethynyluridine was used to label nascent RNA. The results showed that IL-1β could significantly cause injury of nucleus pulposus cells and increase the apoptosis rate of nucleus pulposus cells and the expression of apoptosis protein cleaved-caspase-3 and Bax. At the same time, IL-1β down-regulated the expression of anti-apoptotic protein Bcl-2 and collagen Ⅱ and aggrecan, the main components of ECM. On this basis, AU intervention could improve the injury of nucleus pulposus cells, reduce the apoptosis of nucleus pulposus cells and the expression of cleaved-caspase-3 and Bax, and increase the expression of Bcl-2, collagen Ⅱ, and aggrecan. Compared with IL-1β, AU could up-regulate the phosphorylation level of PI3K and mTOR, and LY294002 could reverse the injury of nucleus pulposus cells and improve ECM degradation induced by AU. In addition, AU also could save lowered rRNA levels of 5S, 18S, and 28S induced by IL-1β and improve RNA synthesis. PI3K inhibitor LY294002 intervention could reduce the promoting effect of AU on ribosome biogenesis. The above results suggest that AU can improve the injury of nucleus pulposus cells and ECM degradation, and its mechanism of action is related to its activation of the PI3K/mTOR pathway to promote ribosome biogenesis.
